Patients, cells, and organelles: The intersection of science and serendipity^†‡

• Pages: 1417-1426
• First Published: 16 March 2011

Histological diagnosis of early hepatocellular carcinoma^†‡

• Pages: 1427-1429
• First Published: 30 March 2011

Telomerase mutation: A genetic risk factor for cirrhosis^†

• Pages: 1430-1432
• First Published: 21 March 2011

Is it the end of the line for the EMT?^†

• Pages: 1433-1435
• First Published: 23 March 2011

Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics^†‡§

• Pages: 1436-1445
• First Published: 14 December 2010

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance^{†‡§¶‖}

• Pages: 1446-1454
• First Published: 28 February 2011

Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice^†

• Pages: 1455-1467
• First Published: 28 February 2011

Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children^†‡

• Pages: 1468-1475
• First Published: 23 February 2011

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1^†

• Pages: 1476-1485
• First Published: 14 February 2011

Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir^†

• Pages: 1486-1493
• First Published: 10 February 2011

Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection^†‡

• Pages: 1494-1503
• First Published: 25 February 2011

Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects^†‡

• Pages: 1504-1514
• First Published: 15 February 2011

Hepatic autophagy mediates endoplasmic reticulum stress–induced degradation of misfolded apolipoprotein B^†

• Pages: 1515-1525
• First Published: 28 February 2011

Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice^†‡

• Pages: 1526-1537
• First Published: 03 March 2011

Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma^†‡

• Pages: 1538-1548
• First Published: 10 February 2011

• Pages: 1549-1557
• First Published: 10 February 2011

Loss of phosphatase and tensin homolog enhances cell invasion and migration through aKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance^†

• Pages: 1558-1569
• First Published: 11 February 2011

Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation^†

• Pages: 1570-1579
• First Published: 11 February 2011

Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas^†

• Pages: 1580-1589
• First Published: 23 February 2011

Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis^†‡

• Pages: 1590-1599
• First Published: 23 February 2011

Constitutional telomerase mutations are genetic risk factors for cirrhosis^†

• Pages: 1600-1607
• First Published: 12 January 2011

Telomerase gene mutations are associated with cirrhosis formation^†‡§

• Pages: 1608-1617
• First Published: 10 February 2011

Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice^†

• Pages: 1618-1628
• First Published: 11 February 2011

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice^†

• Pages: 1629-1640
• First Published: 14 February 2011

Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice ^†

• Pages: 1641-1650
• First Published: 14 December 2010

MicroRNA-221 regulates FAS-induced fulminant liver failure^†‡

• Pages: 1651-1661
• First Published: 15 February 2011

Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury^†

• Pages: 1662-1675
• First Published: 25 February 2011

Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer^†

• Pages: 1676-1684
• First Published: 13 December 2010

Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis^†‡

• Pages: 1685-1695
• First Published: 27 January 2011

Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk^†‡

• Pages: 1696-1707
• First Published: 11 February 2011

Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes^†

• Pages: 1708-1718
• First Published: 25 February 2011

Hepatic differentiation of amniotic epithelial cells^†‡§

• Pages: 1719-1729
• First Published: 03 March 2011

The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91^phox mediate hepatic fibrosis in mice^†‡

• Pages: 1730-1741
• First Published: 07 March 2011

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus^†

• Pages: 1742-1751
• First Published: 03 March 2011

The contribution of endoplasmic reticulum stress to liver diseases^†‡

• Pages: 1752-1763
• First Published: 07 March 2011

The hepcidin circuits act: Balancing iron and inflammation^†

• Pages: 1764-1766
• First Published: 22 April 2011

Neurofibromatosis type 2/merlin: Sharpening the Myth of Prometheus^†

• Pages: 1767-1770
• First Published: 22 April 2011

Massive hepatic echinococcosis ^†‡

• Pages: 1771-1772
• First Published: 22 December 2010

Need for a three-focused approach to nonalcoholic fatty liver disease^†

• Page: 1773
• First Published: 12 November 2010

Reply^†

• Page: 1774
• First Published: 22 April 2011

Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story ^†

• Pages: 1774-1775
• First Published: 27 January 2011

Reply^†

• Pages: 1775-1776
• First Published: 25 February 2011

Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma^†

• Page: 1776
• First Published: 23 February 2011

Patatin-like phospholipase domain-containing protein 3 genotype and hepatocellular carcinoma in chronic hepatitis C^†

• Page: 1777
• First Published: 28 February 2011

The impact of human immunodeficiency virus infection in liver transplantation for hepatocellular carcinoma^†

• Pages: 1777-1778
• First Published: 11 February 2011

Reply^†

• Pages: 1778-1779
• First Published: 28 February 2011

Noninvasive assessment of cystic fibrosis–associated liver disease with acoustic radiation force impulse imaging^†

• Pages: 1779-1780
• First Published: 23 February 2011

Reply: The utility of noninvasive imaging in cystic fibrosis liver disease^†

• Pages: 1780-1781
• First Published: 09 March 2011

Methods and interest of noninvasive assessment of liver fibrosis are still in debate^†

• Page: 1781
• First Published: 07 March 2011

Noninvasive assessment of liver fibrosis: The need for better validation^†

• Pages: 1781-1782
• First Published: 07 March 2011

Reply^†

• Pages: 1782-1783
• First Published: 21 March 2011

Beta-blockers in patients with cirrhosis and refractory ascites^†

• Page: 1783
• First Published: 11 October 2010

Pathogen DNA also contributes to interferon regulatory factor 3 activation in hepatic cells: Implications for alcoholic liver diseases^†

• Pages: 1783-1784
• First Published: 24 November 2010

Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release^†

• Page: 1784
• First Published: 07 December 2010

Is endotoxemia a therapeutic target in liver injury?^†

• Page: 1785
• First Published: 11 January 2011

Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases^†

• Pages: 1785-1786
• First Published: 14 December 2010

Does the donor mannose-binding lectin genotype really predict the risk of bacterial infections after liver transplantation?^†

• Pages: 1786-1787
• First Published: 14 December 2010

• Page: 1788
• First Published: 21 March 2011